Union welcomes EC authorization of TB Alliance’s BPaL treatment for drug-resistant TB

On August 3rd, a new treatment developed by the TB Alliance has been approved by the European Commission for some of the most drug-resistant forms of TB.
Learn more about the new Pretomanid drug here.

Recent Posts

See All

Recent Webinar Slides!

Resist-TB recently hosted Dr. Dookie (Ph.D.) to speak about Individualised management of MDR and XDR-TB in South Africa using Whole Genome Sequencing. Watch the webinar recording here or access th


© 2023 by Last Chance. Proudly created with Wix.com